FAQ

Will there be any announcements when the clinical trial of the allogeneic cartilage cell sheet begins?
Once the first subject has been enrolled, we plan to make an announcement on our website.

A family member has knee problems and is interested in the clinical trial. Is the name of the participating medical institution publicly available?
Information on the medical institutions conducting the clinical trial is available on the Ministry of Health, Labour and Welfare’s "Japan Registry of Clinical Trials (jRCT)." Please refer to the link below.
URL： https://jrct.mhlw.go.jp/en-latest-detail/jRCT2033230587

I am a patient suffering from osteoarthritis of the knee. How can I participate in the clinical trial?
The trial is intended for patients diagnosed with osteoarthritis of the knee who meet specific symptom and progression criteria. Eligibility will be determined based on a medical examination at the participating institution. Recruitment information will be available via the Ministry of Health, Labour and Welfare’s "Japan Registry of Clinical Trials (jRCT)," so please check the site and consult with the relevant medical institution.
URL： https://jrct.mhlw.go.jp/en-latest-detail/jRCT2033230587

Could you provide information on the sales record of your equipment products?
Although we do not disclose detailed sales information, we have been supplying equipment products to researchers both in Japan and overseas for nearly 20 years.
In particular, we have entrusted Thermo Fisher Scientific with overseas sales for over 15 years, delivering globally recognized product performance, quality, and applications to researchers worldwide.

Is it possible to outsource the manufacturing of specific cellular products or regenerative medicine products other than cell sheets?
Yes, we are also able to manufacture products other than cell sheets. If you are interested in our contract manufacturing services, please feel free to contact us.

Why is it that sometimes there is no investor relations (IR) announcement even though a patent has been granted?
In accordance with our internal patent strategy, we determine on a case-by-case basis whether or not to make a public announcement. Please note that we do not disclose patents at the allowance stage if they are not directly related to our development pipeline.

When is the financial results briefing scheduled to take place?
We release video briefings for institutional investors on a semiannual basis. These are scheduled for publication in early March and early September.

Inquiry